Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPHEPBIP | DTAP + HEPB + IPV (PEDIARIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
adult patient needing the hepatitis B vaccine and he inadvertently received the Pediarix vaccine; adult patient inadvertently received the pediarix vaccine; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of wrong vaccine administered in a patient who received DTPa-HBV-IPV (Pediarix) for prophylaxis. Co-suspect products included Hepatitis b vaccine for prophylaxis. On an unknown date, the patient received Pediarix and did not received Hepatitis b vaccine. On an unknown date, an unknown time after receiving Pediarix, the patient experienced wrong vaccine administered (Verbatim: adult patient needing the hepatitis B vaccine and he inadvertently received the Pediarix vaccine) and adult use of a child product (Verbatim: adult patient inadvertently received the pediarix vaccine). The outcome of the wrong vaccine administered and adult use of a child product were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 20-MAR-2025 Clinical Pharmacist specifically had a question in regard to the Pediarix vaccination. They had an adult patient needing the hepatitis B vaccine and he inadvertently received the Pediarix vaccine which led to Adult use of a child product and Wrong vaccine administered. So, pharmacist just wondering if there were any safety concerns or like if have to re-do the hepatitis B vaccine. The pharmacist only knew that the patient was an adult and that he was starting the schedule for hepatitis B vaccine.